Long-term impact of random assignment to intensive lifestyle intervention on Alzheimers disease and related dementias: The Action for Health in Diabetes ADRD Study (Look AHEAD-MIND)
随机分配强化生活方式干预对阿尔茨海默病和相关痴呆症的长期影响:糖尿病 ADRD 研究中的健康行动(Look AHEAD-MIND)
基本信息
- 批准号:9904466
- 负责人:
- 金额:$ 265.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-01 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAffectAgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskBehaviorBehavior TherapyBlood specimenBody Weight decreasedBody mass indexCerebrovascular CirculationClinic VisitsCognitionCognitiveCognitive agingCognitive deficitsComplexDataDatabasesDiabetes MellitusDiseaseElderlyEnergy IntakeEpidemicEpidemiologyEthnic OriginFemaleGenotypeGonadal Steroid HormonesHealthHealth BenefitHealthcareImpaired cognitionImpairmentIndividualInflammationInterventionLaboratoriesLeadLife StyleLinkLong-Term EffectsMinorityNon-Insulin-Dependent Diabetes MellitusObesityOdds RatioOlder PopulationOverweightParticipantPathway interactionsPersonsPhenotypePhysical activityPlayPopulationPrevalencePublic HealthRaceRandomized Clinical TrialsRandomized Controlled Clinical TrialsRecommendationReportingResearchResearch PersonnelResourcesRiskRisk FactorsRoleSample SizeSubgroupTimeWeightadjudicateadjudicationangiogenesisbasebrain healthclinical centercognitive benefitscognitive functioncognitive testingcohortdiet and exercisefollow-uplifestyle interventionmiddle agemild cognitive impairmentmodifiable riskneurovascularrandomized trialresilienceresponsesextherapy design
项目摘要
It is critical to understand the role of lifestyle intervention for the treatment of older adults with type 2 diabetes
mellitus and obesity. Together, these two diseases nearly double one's risk for Alzheimer's disease and related
dementias. The Action for Health in Diabetes (Look AHEAD) randomized controlled clinical trial documented
that 10 years of intensive lifestyle intervention to reduce caloric intake and increase physical activity was
associated with a 30% decrease in the odds of Alzheimer's disease, related dementias, and mild cognitive
impairment in overweight older adults with type 2 diabetes. However, power was limited to establish this
potential benefit firmly [95% CI for odds ratio: 0.40-1.22]. If this finding holds, it provides a powerful message to
support lifestyle interventions in this rapidly growing population. Disturbingly, this intervention was not uniformly
beneficial for all adults. Look AHEAD also reported that among the 837 individuals with the greatest level of
obesity, e.g. body mass index >40 kg/m2, the intensive lifestyle intervention appeared to increase the odds of
Alzheimer's disease, related dementias, and mild cognitive impairment by a factor of 1.46 [0.83-2.56]. Cerebral
blood flow data in this cohort point towards an impaired neurovascular response as the underlying mechanism
for these harmful effects. However, more data are needed to establish these findings and to identify more
firmly the mechanisms underlying the potential benefits and harms that have been observed. Look AHEAD, the
only long-term randomized trial of lifestyle intervention in persons with type 2 diabetes, provides the
unprecedented and timely opportunity to assess the legacy that a successful, sustained, and well-documented
lifestyle intervention has on cognitive resilience and the risk of Alzheimer's disease, related dementia, and mild
cognitive impairment in a large and diverse cohort drawn from clinical centers across the US.
The Action for Health in Diabetes Alzheimer's Disease and Related Dementias Study (Look AHEAD-MIND)
that we propose will answer the question of whether interventions designed to induce and sustain long term
weight losses lead to cognitive benefit in some, or harm in others, and determine the role that baseline weight
plays in modifying this association. We propose to repeat the cognitive assessment and adjudication of
cognitive impairment in the cohort (N=3,500), more than doubling the number of cases: to confirm findings and
identify potential mechanisms for benefit (inflammation, sex hormones) and harm (angiogenesis). Combining
the rich characterization of the Look AHEAD cohort over nearly 20 years with these incident cases and
cognitive trajectories (two-thirds of the cohort has had only one cognitive assessment), we will identify factors
related to cognitive resilience. We will also develop public-use databases to promote research on cognitive
health in the rapidly growing and understudied population of older individuals who are overweight or obese and
have type 2 diabetes. We respond to PAR-15-356.
了解生活方式干预在治疗2型糖尿病的老年人中的作用至关重要
Mellitus和肥胖。这两种疾病在一起几乎是一个人患阿尔茨海默氏病的风险及相关的风险
痴呆症。糖尿病中健康动作(前进)随机对照临床试验记录了
减少热量摄入和增加体育锻炼的十年密集的生活方式干预措施是
与阿尔茨海默氏病,相关痴呆和轻度认知的几率下降30%有关
超重老年人患有2型糖尿病的损害。但是,力量仅限于建立这个
潜在的收益牢固[赔率为95%CI:0.40-1.22]。如果这一发现成立,它提供了一个强大的信息
支持这种迅速增长的人口的生活方式干预措施。令人不安的是,这种干预并不统一
对所有成年人有益。展望未来还报告说,在837个人中
肥胖,例如体重指数> 40 kg/m2,密集的生活方式干预似乎增加了几率
阿尔茨海默氏病,相关的痴呆症和轻度认知障碍倍数1.46 [0.83-2.56]。大脑
该队列中的血流数据指向神经血管反应受损的基本机制
这些有害影响。但是,需要更多数据来建立这些发现并确定更多
牢固地观察到了潜在的益处和危害的基础机制。向前看,
只有对2型糖尿病患者的生活方式干预的长期随机试验才能提供
空前且及时的机会来评估成功,持续和据可记录的遗产
生活方式干预对认知韧性和阿尔茨海默氏病,相关痴呆和温和的风险
来自美国临床中心的大型和多样化的队列中的认知障碍。
阿尔茨海默氏病和相关痴呆症研究中健康状况的作用(提前查看)
我们建议将回答旨在诱导和维持长期干预措施的问题
体重减轻会导致某些人的认知益处,或者在其他方面受到伤害,并确定基线重量的作用
扮演修改该关联。我们建议重复认知评估和裁决
队列中的认知障碍(n = 3,500),案例数量增加了一倍以上:确认发现和
确定益处(炎症,性激素)和危害(血管生成)的潜在机制。结合
这些事件案件和
认知轨迹(三分之二的队列只有一个认知评估),我们将确定因素
与认知弹性有关。我们还将开发公共用途数据库以促进认知研究
超重或肥胖的老年人的迅速成长且研究不足的人口
患有2型糖尿病。我们回应15-356杆。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK Andrew ESPELAND其他文献
MARK Andrew ESPELAND的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK Andrew ESPELAND', 18)}}的其他基金
Action for Health in Diabetes (Look AHEAD) Extended Follow-up (LA-E2)
糖尿病健康行动(前瞻性)延长随访 (LA-E2)
- 批准号:
10879341 - 财政年份:2021
- 资助金额:
$ 265.9万 - 项目类别:
Action for Health in Diabetes (Look AHEAD) Extended Follow-up (LA-E2)
糖尿病健康行动(前瞻性)延长随访 (LA-E2)
- 批准号:
10293012 - 财政年份:2021
- 资助金额:
$ 265.9万 - 项目类别:
Action for Health in Diabetes (Look AHEAD) Extended Follow-up (LA-E2)
糖尿病健康行动(前瞻性)延长随访 (LA-E2)
- 批准号:
10457419 - 财政年份:2021
- 资助金额:
$ 265.9万 - 项目类别:
Action for Health in Diabetes (Look AHEAD) Extended Follow-up (LA-E2)
糖尿病健康行动(前瞻性)延长随访 (LA-E2)
- 批准号:
10698054 - 财政年份:2021
- 资助金额:
$ 265.9万 - 项目类别:
Brain Insulin Resistance and Development of Alzheimers Disease
脑胰岛素抵抗与阿尔茨海默病的发展
- 批准号:
9904967 - 财政年份:2018
- 资助金额:
$ 265.9万 - 项目类别:
Study of Novel Approaches to Weight Gain Prevention - Extension (SNAP-E)
预防体重增加新方法的研究 - 扩展 (SNAP-E)
- 批准号:
8985911 - 财政年份:2015
- 资助金额:
$ 265.9万 - 项目类别:
相似国自然基金
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
恒星模型中氧元素丰度的变化对大样本F、G、K矮星年龄测定的影响
- 批准号:12303035
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于年龄和空间的非随机混合对性传播感染影响的建模与研究
- 批准号:12301629
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
中国东部地区大气颗粒物的年龄分布特征及其影响因素的模拟研究
- 批准号:42305193
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
- 批准号:
10748606 - 财政年份:2024
- 资助金额:
$ 265.9万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 265.9万 - 项目类别:
Understanding the Mechanisms and Consequences of Basement Membrane Aging in Vivo
了解体内基底膜老化的机制和后果
- 批准号:
10465010 - 财政年份:2023
- 资助金额:
$ 265.9万 - 项目类别:
Safety and Tolerability of TASIS-Peanut (Targeted Allergen Specific Immunotherapy within the Skin) patch for the Treatment of Peanut Allergy
TASIS-花生(皮肤内靶向过敏原特异性免疫疗法)贴剂治疗花生过敏的安全性和耐受性
- 批准号:
10551184 - 财政年份:2023
- 资助金额:
$ 265.9万 - 项目类别:
Sustained eIF5A hypusination at the core of brain metabolic dysfunction in TDP-43 proteinopathies
持续的 eIF5A 抑制是 TDP-43 蛋白病脑代谢功能障碍的核心
- 批准号:
10557547 - 财政年份:2023
- 资助金额:
$ 265.9万 - 项目类别: